APA

Pitot H. C., Wender D. B., O'Connell M. J., Schroeder G., Goldberg R. M., Rubin J., Mailliard J. A., Knost J. A., Ghosh C., Kirschling R. J., Levitt R. & Windschitl H. E. (19970908). Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Pitot H C, Wender D B, O'Connell M J, Schroeder G, Goldberg R M, Rubin J, Mailliard J A, Knost J A, Ghosh C, Kirschling R J, Levitt R and Windschitl H E. 19970908. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Pitot H. C., Wender D. B., O'Connell M. J., Schroeder G., Goldberg R. M., Rubin J., Mailliard J. A., Knost J. A., Ghosh C., Kirschling R. J., Levitt R. and Windschitl H. E. (19970908). Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Pitot H C, Wender D B, O'Connell M J, Schroeder G, Goldberg R M, Rubin J, Mailliard J A, Knost J A, Ghosh C, Kirschling R J, Levitt R and Windschitl H E. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19970908.